
Gemcitabine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for solution for injection/infusion
Available Strengths: 200 mg, 1000 mg, 1500 mg
Reference Brands: Gemzar® (US & EU)
Category: Oncology Cancer Care
Gemcitabine is available in Lyophilized powder for solution for injection/infusion and strengths such as 200 mg, 1000 mg, 1500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Gemcitabine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Gemcitabine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Gemcitabine is a widely used oncology chemotherapy drug available in both the US and EU pharmaceutical B2B markets. Offered in 200 mg, 1 g, and 1.5 g vials, Gemcitabine comes as a lyophilized powder for intravenous infusion. Trusted by hospitals and oncology centers, it is essential for treating cancers such as pancreatic, lung, bladder, and breast cancer. Approved by the FDA and EMA, Gemcitabine is available through certified pharmaceutical wholesalers and B2B distributors across Europe and the United States. Buyers seeking reliable Gemcitabine suppliers can access competitive pricing, consistent quality, and regulatory-compliant sourcing for hospital and clinical use.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers